TEM insider files Form 144 reporting 10,949 RSUs sale (NASDAQ: TEM)

Rhea-AI Filing Summary

TEM insider filed Form 144 reporting an intended sale of 10,949 restricted stock units.

The filing lists prior 10b5-1 sales of 8,143 shares on 02/19/2026 for $457,310.88 and 12,874 shares on 11/24/2025 for $965,550.00. The filing identifies brokerage information dated 02/20/2026.

Insights

Insider Transactions Analyst

Routine Form 144 lists an intended sale of 10,949 RSUs and recent 10b5-1 sales.

The filing shows an intended disposition of 10,949 restricted stock units and records two recent 10b5-1 sales: 8,143 shares on 02/19/2026 and 12,874 shares on 11/24/2025, with proceeds reported.

These entries are administrative disclosures of planned and completed insider sales; cash-flow treatment and further specifics about who will receive proceeds are not detailed in the excerpt.

FAQ

What did the TEM Form 144 report?

It reported an intended sale of 10,949 restricted stock units. The filing also lists prior 10b5-1 sales of 8,143 shares on 02/19/2026 and 12,874 shares on 11/24/2025, with reported proceeds.

Who executed recent 10b5-1 sales for TEM?

The filing lists Andrew Polovin as a seller tied to 10b5-1 sales. The excerpt shows sales of 8,143 shares on 02/19/2026 and 12,874 shares on 11/24/2025, with stated proceeds.

How much cash was generated from the recent insider sales?

The excerpt reports proceeds of $457,310.88 for the 02/19/2026 sale and $965,550.00 for the 11/24/2025 sale. Those amounts are shown alongside the listed share counts.

Does the Form 144 state when the intended sale will occur?

The filing lists the intended sale date as 02/19/2026 for the 10,949 RSUs. The document ties brokerage information to 02/20/2026 but does not add further timing details.

Will TEM receive proceeds from these sales?

The Form 144 shows insider resale activity and does not state that TEM will receive proceeds. The excerpt identifies these as insider sales; cash‑flow recipient information is not provided in the text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002024169
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tempus AI, Inc.
SEC File Number	001-42130
Address of Issuer	600 WEST CHICAGO AVENUE, SUITE 510 CHICAGO ILLINOIS 60654
Phone	8009765448
Name of Person for Whose Account the Securities are To Be Sold	ANDREW POLOVIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10949	656502.04	172863470	02/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2026	Restricted Stock Units	Issuer			10949	02/19/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW POLOVIN 600 WEST CHICAGO AVENUE, SUITE 510 CHICAGO IL 60654	Common	02/19/2026	8143	457310.88
10b5-1 Sales for ANDREW POLOVIN 600 WEST CHICAGO AVENUE, SUITE 510 CHICAGO IL 60654	Common	11/24/2025	12874	965550.00

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Polovin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)